Manufacturing Omeprazole Injection 40 mg (By Den Mark Pharmaceuticals Pvt. Ltd.)

Den Mark Pharmaceuticals Pvt. Ltd. is committed to producing high-quality pharmaceutical products adhering to WHO-GMP guidelines and is a GMP-certified pharmaceutical exporter. This document outlines the manufacturing process for Omeprazole Injection 40mg, a proton pump inhibitor used to treat gastrointestinal disorders..

1. Starting Materials and Documentation:

  • Obtain high-quality Omeprazole API (Active Pharmaceutical Ingredient) and excipients (inactive ingredients) from qualified suppliers with valid Certificates of Analysis (CoA).
  • Maintain a documented receiving procedure, ensuring proper identification, quarantine, and sampling for testing against specifications.

2. Pre-Production:

  • Review production orders, ensuring all materials, equipment, and personnel are available.
  • Prepare a detailed Batch Production Record (BPR) documenting every step.
  • Calibrate and qualify all equipment involved in the production process.

3. Weighing and Dispensing:

  • Aseptically weigh the required quantities of Omeprazole API and excipients under a Laminar Airflow (LAF) hood.
  • Double-check the weights by a qualified person.

4. Mixing and Dissolving:

  • Transfer the weighed materials to a sterilized mixing vessel.
  • Use purified water for injection (WFI) to prepare the solution, following validated mixing procedures.
  • Ensure complete dissolution and uniformity of the solution.

5. Filtration:

  • Pass the solution through pre-sterilized filters with a pore size appropriate to remove any particulate matter.
  • Verify filter integrity after use.

6. Filling and Sealing:

  • Transfer the sterile solution to pre-sterilized vials (40 mg/vial).
  • Utilize a validated aseptic filling line to minimize contamination risks.
  • Ensure proper vial closure with sterilized stoppers and seals.

7. Lyophilization (Freeze Drying):

  • Load the filled Omeprazole Injection 40 mg vials into a lyophilizer and follow a validated freeze-drying cycle.
  • This process removes water content while maintaining product stability

8. Sterilization:>

  • Depending on the chosen container-closure system, employ a validated sterilization method, such as aseptic filtration or terminal sterilization.
  • Document the sterilization cycle parameters and monitor them throughout the process.

9. In-Process Quality Control:

  • Conduct sampling and testing at designated checkpoints throughout the process.
  • Analyze Omeprazole Injection 40 mg samples for pH, sterility, and active ingredient concentration according to pre-defined specifications.
  • Reject batches that fail to meet quality standards.

10. Labeling and Packaging:>

  • Apply pre-printed labels on finished Omeprazole Injection 40 mg vials containing product information, batch number, expiry date, and manufacturer details.
  • Package the labeled Omeprazole Injection 40 mg vials in sterilized cartons following GMP guidelines.

11. Quarantine and Release:

  • Quarantine the finished Omeprazole Injection 40 mg batch until all quality control tests are complete and approved.
  • Release the batch only after a qualified person reviews the BPR and verifies compliance with specifications.

12. Documentation and Records Management:

  • Maintain comprehensive documentation for all production activities, including BPRs, raw material certificates, equipment calibration records, and quality control data.
  • Archive all documents as per regulatory requirements.

Additional Considerations:

  • Employ a trained and qualified workforce adhering to GMP regulations.
  • Maintain a clean and hygienic production environment.
  • Implement a robust Quality Management System for continuous process improvement.
  • Conduct regular audits to ensure GMP compliance.

By following these steps and adhering to WHO GMP guidelines, Den Mark Pharmaceuticals Pvt. Ltd. can ensure the consistent production of high-quality, safe, and productive Omeprazole Injection 40 mg.